![Raul Krauss](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raul Krauss
Founder at Disarm Therapeutics, Inc.
Network origin in Raul Krauss first degree
Entity | Entity type | Industry | |
---|---|---|---|
Disarm Therapeutics, Inc.
![]() Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA.
15
| Subsidiary | Biotechnology | 15 |
Apple Tree venture Managemnet Llc//vc
![]() Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge.
2
| Private Company | Investment Managers | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Raul Krauss via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree | |
Stanford University | College/University | Undergraduate Degree | |
Vanderbilt University | College/University | Undergraduate Degree | |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
Northeastern University
![]() Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin Masters Business Admin | |
Princeton University | College/University | Undergraduate Degree | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
Biogen Idec, Inc. (North Carolina)
![]() Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sidney Kimmel Medical College | College/University | Doctorate Degree | |
American Academy of Neurology
![]() American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Longwood Fund Management LLC
![]() Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
PhRMA Foundation
![]() PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Miscellaneous Commercial Services | Chairman | |
SRI Consulting, Inc.
![]() SRI Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services SRI Consulting, Inc. provides information technology and business support services. It specializes in the development, implementation and maintenance of software solutions. The company was founded by Philip C. Sharpe in 1995 and is headquartered in Fairfax, VA. | Miscellaneous Commercial Services | Consultant / Advisor | |
TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kellogg School of Management | College/University | Masters Business Admin | |
The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal | |
The University of Alabama School of Medicine | College/University | Doctorate Degree | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Padlock Therapeutics, Inc.
![]() Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Atlas Venture Life Science Advisors LLC
![]() Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Verge Analytics, Inc.
![]() Verge Analytics, Inc. BiotechnologyHealth Technology Verge Analytics, Inc. engages in the provision of biotechnology services. It develops drugs for neurodegenerative diseases using computational genomics. The company was founded by Alice Zhang and Jason Chen in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Gemini Therapeutics Sub, Inc.
![]() Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member | |
GENERATION BIO CO. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
Enzyvant, Inc.
![]() Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Executive Officer | |
DYNE THERAPEUTICS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
Cure Sma | Director/Board Member | ||
Atalanta Therapeutics, Inc.
![]() Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Miscellaneous Commercial Services | Director/Board Member | |
Catamaran Bio, Inc.
![]() Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Chief Executive Officer | |
Be Biopharma, Inc.
![]() Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Rectify Pharmaceuticals LLC
![]() Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
AAVantgarde Bio Srl
![]() AAVantgarde Bio Srl Miscellaneous Commercial ServicesCommercial Services AAVantgarde Bio Srl is a clinical stage biotechnology start-up based in Milan, Italy. The Italian company has developed proprietary adeno-associated viral (AAV) vector platforms that allow for the delivery of large genes for inherited retinal disorders. Co-founded by Professor Alberto Auricchio and originating from the research activities carried out at TIGEM (Telethon Institute of Genetics and Medicine), AAVantgarde's platforms are focused on broadening the application of AAV-based therapies by addressing the limitations of single AAV therapies cargo capacity. Natalia Misciattelli has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Transition Bio, Inc.
![]() Transition Bio, Inc. BiotechnologyHealth Technology Transition Bio, Inc. is a company based in Watertown, MA that is developing technologies for biomolecular condensate analysis. The company's proprietary drug discovery platform, CondensomicsTM, utilizes droplet microfluidics and machine learning to map and modulate condensates in molecular detail. The company's goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. Transition Bio has been founded by Sarah Teichmann, David A. Weitz, Peter H. St George-Hyslop, and Tuomas Knowles. | Biotechnology | Director/Board Member | |
K36 Therapeutics, Inc.
![]() K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
Exceptional Ventures LLP
![]() Exceptional Ventures LLP Investment ManagersFinance Exceptional Ventures LLP (Exceptional Ventures) is a venture capital firm founded in 2022. The firm is headquartered in London, the United Kingdom. | Investment Managers | Consultant / Advisor | |
Rare-X
![]() Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Packaged Software | Director/Board Member |
Statistics
International
United States | 46 |
Ireland | 2 |
Germany | 2 |
Italy | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 23 |
Consumer Services | 12 |
Commercial Services | 9 |
Finance | 6 |
Health Services | 2 |
Operational
Director/Board Member | 85 |
Corporate Officer/Principal | 35 |
Founder | 23 |
Chief Tech/Sci/R&D Officer | 21 |
Private Equity Investor | 20 |
Most connected contacts
Insiders | |
---|---|
Jean George | 33 |
Gregory Verdine | 25 |
Jason Rhodes | 24 |
Catherine Stehman-Breen | 16 |
Alfred Sandrock | 16 |
Douglas Kerr | 13 |
Rajesh Devraj | 12 |
Scott C. Chappel | 12 |
John Gustofson | 12 |
Alvin Shih | 11 |
Kimi Iguchi | 10 |
Gerhard Koenig | 7 |
Tom Engber | 6 |
Robert Hughes | 4 |
Jeffrey D Milbrandt | 2 |
- Stock Market
- Insiders
- Raul Krauss
- Company connections